Cargando…
Angiogenesis - still a worthwhile target for breast cancer therapy?
Autores principales: | Lord, Simon, Harris, Adrian L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005739/ https://www.ncbi.nlm.nih.gov/pubmed/21172081 http://dx.doi.org/10.1186/bcr2748 |
Ejemplares similares
-
Tailored targeted therapy for all: a realistic and worthwhile objective?
por: Lønning, Per Eystein
Publicado: (2009) -
Tailored targeted therapy for all: a realistic and worthwhile objective against
por: Pritchard, Kathleen I
Publicado: (2009) -
Staging Laparoscopy for Hilar Cholangiocarcinoma: Is it Still Worthwhile?
por: Ruys, Anthony T., et al.
Publicado: (2011) -
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
por: Lord, Simon R., et al.
Publicado: (2023) -
Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
por: Di Cosimo, Serena
Publicado: (2009)